T

TiumBio Co Ltd
KOSDAQ:321550

Watchlist Manager
TiumBio Co Ltd
KOSDAQ:321550
Watchlist
Price: 5 200 KRW -3.53% Market Closed
Market Cap: 143.9B KRW

Operating Margin

-199.2%
Current
Improving
by 119%
vs 3-y average of -318.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-199.2%
=
Operating Income
₩-18.6B
/
Revenue
₩9.3B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-199.2%
=
Operating Income
₩-18.6B
/
Revenue
₩9.3B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
TiumBio Co Ltd
KOSDAQ:321550
141.2B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
186.7B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
162.9B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.6B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.8B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.8B USD
Loading...

Market Distribution

Lower than 96% of companies in Korea
Percentile
4rd
Based on 2 615 companies
4rd percentile
-199.2%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

TiumBio Co Ltd
Glance View

Market Cap
143.9B KRW
Industry
Biotechnology

TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.

TiumBio Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-199.2%
=
Operating Income
₩-18.6B
/
Revenue
₩9.3B
What is TiumBio Co Ltd's current Operating Margin?

The current Operating Margin for TiumBio Co Ltd is -199.2%, which is above its 3-year median of -318.2%.

How has Operating Margin changed over time?

Over the last 3 years, TiumBio Co Ltd’s Operating Margin has increased from -825.3% to -199.2%. During this period, it reached a low of -825.3% on Aug 30, 2022 and a high of -199.2% on Oct 30, 2025.

Back to Top